Radiation doses to mediastinal organs at risk in early-stage unfavorable Hodgkin lymphoma– a risk stratified analysis of the GHSG HD17 trial

IntroductionThe German Hodgkin Study Group (GHSG) HD17 trial established the omission of radiotherapy (RT) for patients with early-stage unfavorable Hodgkin lymphoma being PET-negative after 2 cycles of BEACOPP escalated plus 2 cycles of ABVD. This patient group reveals heterogeneity in characterist...

Descripció completa

Dades bibliogràfiques

Autors principals:	Michael Oertel, Dominik Hering, Christian Baues, Christopher Kittel, Michael Fuchs, Jan Kriz, Kai Kröger, Dirk Vordermark, Klaus Herfarth, Rita Engenhart-Cabillic, Peter Lukas, Uwe Haverkamp, Peter Borchmann, Hans Theodor Eich
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2023-05-01
Col·lecció:	Frontiers in Oncology
Matèries:	radiation oncology radiation treatment involved-node radiotherapy involved-field radiotherapy survivorship dosimetry
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1183906/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!